NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	244.82B +92.9%
Revenue (ttm)	385.76B +32.1%
Net Income	36.10B +92.4%
EPS	2,039.00 +92.4%
Shares Out	17.70M
PE Ratio	6.78
Forward PE	n/a
Dividend	200.00 (1.45%)
Ex-Dividend Date	Dec 29, 2025

Volume	94,278
Average Volume	89,791
Open	14,300
Previous Close	14,240
Day's Range	13,800 - 14,300
52-Week Range	8,160 - 22,100
Beta	0.23
RSI	38.28
Earnings Date	Mar 20, 2026

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 464
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.